Show simple item record

dc.contributor.authorLamarca, Angela
dc.contributor.authorPalmer, DH
dc.contributor.authorWasan, HS
dc.contributor.authorRoss, PJ
dc.contributor.authorMa, YT
dc.contributor.authorArora, A
dc.contributor.authorFalk, S
dc.contributor.authorGillmore, R
dc.contributor.authorWadsley, J
dc.contributor.authorPatel, K
dc.contributor.authorAnthoney, A
dc.contributor.authorMaraveyas, A
dc.contributor.authorIveson, T
dc.contributor.authorWaters, JS
dc.contributor.authorBlesing, C
dc.contributor.authorBarber, S
dc.contributor.authorRyder, D
dc.contributor.authorRamage, J
dc.contributor.authorDavies, L
dc.contributor.authorBridgewater, JA
dc.contributor.authorValle, Juan W
dc.date.accessioned2020-01-29T15:17:53Z
dc.date.available2020-01-29T15:17:53Z
dc.date.issued2019en
dc.identifier.citationLamarca A, Palmer D, Wasan H, Ross P, Ma Y, Arora A, et al. ABC-06 vertical bar a randomised phase III study of active symptom control (ASC) with/without mFOLFOX after progression to cisplatin-gemcitabine chemotherapy for patients with advanced biliary tract cancers. British Journal of Cancer. 2019;121:19en
dc.identifier.urihttp://hdl.handle.net/10541/622700
dc.language.isoenen
dc.titleABC-06 vertical bar a randomised phase III study of active symptom control (ASC) with/without mFOLFOX after progression to cisplatin-gemcitabine chemotherapy for patients with advanced biliary tract cancersen
dc.typeMeetings and Proceedingsen
dc.contributor.departmentThe Christie NHS Foundation Trust, Manchesteren
dc.identifier.journalBritish Journal of Canceren
dc.description.noteen]


This item appears in the following Collection(s)

Show simple item record